Expected Spesolimab Plasma Exposure following Intravenous and Subcutaneous Dosing in Patients with Generalized Pustular Psoriasis. (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s359. https://doi.org/10.25251/skin.8.supp.359